Related Experiment Video
Updated: Apr 25, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Short-, mid-, and long-term benefits of peri-procedural high-intensity statin administration in patients undergoing
Vasilios G Athyros1, Niki Katsiki, Asterios Karagiannis
1Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocrates Hospital , Thessaloniki , Greece.
Insights
High-intensity statin therapy before percutaneous coronary intervention (PCI) significantly reduces cardiovascular disease (CVD) and overall mortality. These findings support pre-PCI statin administration for improved patient outcomes.
Area of Science:
- Cardiology
- Pharmacology
Background:
- High-intensity statin therapy before percutaneous coronary intervention (PCI) is associated with reduced cardiovascular disease (CVD) morbidity and mortality.
- This contrasts with lower-intensity statins or no statin treatment.
Discussion:
- Pleiotropic effects of statins, including improved endothelial function, reduced inflammation, and decreased thrombotic diathesis, are likely mechanisms.
- Statins may reduce cardiac injury, myocardial infarction, and the no-reflow phenomenon post-PCI.
- Reduced risk of contrast-induced nephropathy (CIN) post-PCI may also contribute to improved mortality outcomes.
Key Insights:
- Pre-PCI high-intensity statin administration is linked to better short-, mid-, and long-term cardiovascular and overall survival.
- Mechanisms involve both direct cardiac benefits and extracardiac effects like reduced CIN.
- The study underscores the importance of statin use in patients undergoing PCI.
Outlook:
- Further research into the specific pleiotropic mechanisms and their clinical impact is warranted.
- Optimizing statin regimens prior to PCI could be a key strategy in managing coronary artery disease.
- Investigating the long-term benefits and cost-effectiveness of high-intensity statin pre-treatment is crucial.
Abstract:
Administration of high intensity statins prior to percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) or stable coronary artery disease has been shown to reduce short-, mid-, and long-term cardiovascular disease (CVD) morbidity and mortality as well as overall mortality compared with lower intensity statins or no statin treatment. The mechanisms involved are probably related to the pleiotropic effects of statins. Improved endothelial function, reduced low grade inflammation and decreased thrombotic diathesis might reduce cardiac injury, diffuse cardiac necrosis, myocardial infarction and no-reflow phenomenon. A decreased risk of contrast-induced nephropathy (CIN) post-PCI might be an extracardiac mechanism that contributes to the reduction in all cause and CVD mortality. These results support the need for the administration of statins before PCI.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
10:01Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
Published on: March 12, 2018
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Coronary Artery Disease V: Interprofessional Care
Cardiac Catheterization IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Imaging Studies for Cardiovascular System V: CT